Defects in the interleukin (IL)-7 signal transduction pathway lead to severe immunodeficiency in humans and in mice. In IL-7 receptor–deficient (IL-7R−/−) mice, lymphoid precursors show a reduced survival rate and variable/diversity/joining region V(D)J recombination is variously affected in different loci, being arrested in the T cell receptor (TCR)-γ locus, aberrant in the immunoglobulin heavy chain (IgH) locus, and delayed in the TCR-β locus. Here, we analyze the recombination defect of the TCR-γ locus. Using ligation-mediated polymerase chain reaction, we sought intermediates of the recombination process. In the absence of the IL-7 signal, no initiation of recombination of the TCR-γ locus was observed, whereas recombination intermediates at the TCR-β locus could be detected. Thus, the failure to rearrange the TCR-γ locus is due to a failure to initiate cleavage rather than a failure to religate broken DNA ends. V(D)J recombination was previously thought to begin at the pro-T2 stage of T cell development after the arrest of IL-7R−/− thymocytes at the pro-T1 stage. However, here we show that both TCR-γ and -β recombination intermediates are readily detectable in normal T1 cells, but only TCR-β intermediates were detected in IL-7R−/− T1 cells, supporting a mechanistic role for IL-7 in TCR-γ locus rearrangement. Since reduced recombination activating gene (rag) expression has been reported in the absence of the IL-7 signal, we directly tested whether the TCR-γ locus is accessible to cleavage by recombinant Rag proteins in vitro. We found a reduction in chromatin accessibility for Rag-mediated cleavage in IL-7R−/− thymocytes compared with wild-type. Thus, IL-7 controls recombination at the TCR-γ locus by regulating locus accessibility.
Skip Nav Destination
Article navigation
20 March 2000
Brief Definitive Report|
March 20 2000
The Interleukin 7 Receptor Is Required for T Cell Receptor γ Locus Accessibility to the V(D)j Recombinase
Mark S. Schlissel,
Mark S. Schlissel
aDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720-3200
Search for other works by this author on:
Scott D. Durum,
Scott D. Durum
bLaboratory of Molecular Immunoregulation, Science Applications International Corporation (SAIC) Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201
Search for other works by this author on:
Kathrin Muegge
Kathrin Muegge
bLaboratory of Molecular Immunoregulation, Science Applications International Corporation (SAIC) Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201
cIntramural Research Support Program, Science Applications International Corporation (SAIC) Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201
Search for other works by this author on:
Mark S. Schlissel
aDepartment of Molecular and Cell Biology, University of California, Berkeley, California 94720-3200
Scott D. Durum
bLaboratory of Molecular Immunoregulation, Science Applications International Corporation (SAIC) Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201
Kathrin Muegge
bLaboratory of Molecular Immunoregulation, Science Applications International Corporation (SAIC) Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201
cIntramural Research Support Program, Science Applications International Corporation (SAIC) Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702-1201
Received:
September 27 1999
Revision Requested:
December 22 1999
Accepted:
December 24 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (6): 1045–1050.
Article history
Received:
September 27 1999
Revision Requested:
December 22 1999
Accepted:
December 24 1999
Citation
Mark S. Schlissel, Scott D. Durum, Kathrin Muegge; The Interleukin 7 Receptor Is Required for T Cell Receptor γ Locus Accessibility to the V(D)j Recombinase. J Exp Med 20 March 2000; 191 (6): 1045–1050. doi: https://doi.org/10.1084/jem.191.6.1045
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement